Recall: D-1058-2022
Class II - Potentially Harmful
Class IIClassification
2022-04-13Initiated
TerminatedStatus
Mckesson Medical-Surgical Inc.Firm
Product
Sodium Bicarbonate Tablets, 600 mg, 1000-count bottle, MFG: Major Pharma, NDC 0536-1047-10
Reason
cGMP deviations: Temperature abuse
Distribution
USA nationwide.
Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.